Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus
Objective Osteoporosis is a common comorbidity in patients with SLE, and bone loss in patients with SLE has a multifactorial aetiology. This study aimed to evaluate the therapeutic efficacy of denosumab in patients with SLE with osteoporosis and to analyse the factors influencing therapeutic efficac...
Saved in:
Main Authors: | Sung-Hwan Park, Seung-Ki Kwok, Wan-Uk Kim, Ji Hyeon Ju, Jiwon Yang, Youngjae Park, Jennifer Jooha Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/12/1/e001438.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of glucocorticoids on the therapeutic efficacy of denosumab against osteoporosis in patients with rheumatoid arthritis
by: Jiwon Yang, et al.
Published: (2025-01-01) -
The prevalence, clinical features, and long-term outcome of patients with primary Sjögren’s syndrome with renal involvement
by: Howook Jeon, et al.
Published: (2025-02-01) -
Recapitulation of Candidate Systemic Lupus Erythematosus-Associated Variants in Koreans
by: Ki-Sung Kwon, et al.
Published: (2016-09-01) -
Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
by: Hui-Yuan Li, et al.
Published: (2023-01-01) -
Systemic Lupus Erythematosus
by: Chaim Putterman, et al.
Published: (2012-01-01)